Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
CRISPR Therapeutics AG
(NASDAQ:CRSP)
45.48
Delayed Data
As of Sep 22
-0.58
/
-1.26%
Today’s Change
38.94
Today
|||
52-Week Range
72.00
+11.88%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest CRSP News
|
Press Releases
CRISPR Therapeutics AG (CRSP) Stock Moves -1.07%: What You Should Know
Sep 21 / Zacks.com - Paid Partner Content
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
Sep 16 / MotleyFool.com - Paid Partner Content
$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years
Sep 21 / MotleyFool.com - Paid Partner Content
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know
Sep 15 / Zacks.com - Paid Partner Content
Better Growth Stock: CRISPR Therapeutics vs. Bluebird Bio
Sep 20 / MotleyFool.com - Paid Partner Content
Better Growth Stock: Recursion Pharmaceuticals vs. CRISPR Therapeutics
Sep 15 / MotleyFool.com - Paid Partner Content
Where Will CRISPR Therapeutics Be in 5 Years?
Sep 19 / MotleyFool.com - Paid Partner Content
3 Top Healthcare Stocks Defying the Bear Market
Sep 15 / MotleyFool.com - Paid Partner Content
1 Huge Risk That Gene-Editing Stock Investors Desperately Need to Know
Sep 19 / MotleyFool.com - Paid Partner Content
Better Bull Market Buy: CRISPR vs. Medtronic Stock
Sep 14 / MotleyFool.com - Paid Partner Content
Vertex (VRTX) Gets Positive CHMP Opinion for Kaftrio Expanded Use
Sep 18 / Zacks.com - Paid Partner Content
More Likely to 5x First: Bluebird Bio vs. CRISPR Therapeutics
Sep 12 / MotleyFool.com - Paid Partner Content
2 Top Trends to Invest $500 In Right Now
Sep 18 / MotleyFool.com - Paid Partner Content
2 No-Brainer Biotech Stocks to Buy Right Now
Sep 12 / MotleyFool.com - Paid Partner Content
Looking for Growth? These Companies' Revenue May Skyrocket
Sep 17 / MotleyFool.com - Paid Partner Content